Sotera Health Co SHC
2 targets with a reported result
Releases of the last 3 yearsThe numbers SHC said it expected, in its earnings releases, next to what it then reported for the same period.
Target by target
Each target, with the sentence it came from · release and 10-Q or 10-K
| Target | What the company said | Reported | Result | |
|---|---|---|---|---|
| EBITDA (company-defined) Fiscal 2026 |
Given $632.00M to $641.00M release Feb 24, 2026
Kept $632.00M to $641.00M release May 5, 2026
Raised $634.00M to $643.00M release Aug 6, 2026
Lowered $632.00M to $641.00M release Nov 3, 2026
|
– | No standard number | |
The company's wordsFull-Year 2026 Outlook … Adjusted EBITDA in the range of $632 million to $641 million, representing constant currency growth of 5.5% to 7.0% and an estimated 100bps foreign currency benefit release Feb 24, 2026 The 2026 outlook below, first provided on February 24, 2026, remains unchanged: … Adjusted EBITDA in the range of $632 million to $641 million, representing constant currency growth of 5.5% to 7.0% and an estimated 100bps foreign currency benefit release May 5, 2026 Today, Sotera Health is raising its 2026 outlook: … Adjusted EBITDA range raised to $634 million to $643 million, representing constant currency growth of 5.75% to 7.25% and an estimated 100 basis points of foreign currency benefit release Aug 6, 2026 Full-Year 2026 Outlook … Adjusted EBITDA in the range of $632 million to $641 million, representing constant currency growth of 5.75% to 7.25%. release Nov 3, 2026 | ||||
| Capital expenditures Fiscal 2026 |
Given $175.00M to $225.00M release Feb 24, 2026
Kept $175.00M to $225.00M release May 5, 2026
Raised $200.00M to $225.00M release Aug 6, 2026
Kept $200.00M to $225.00M release Nov 3, 2026
|
– | Not reported yet | |
The company's wordsFull-Year 2026 Outlook … Capital expenditures in the range of $175 million to $225 million release Feb 24, 2026 The 2026 outlook below, first provided on February 24, 2026, remains unchanged: … Capital expenditures in the range of $175 million to $225 million release May 5, 2026 Today, Sotera Health is raising its 2026 outlook: … Capital expenditures in the range of $200 million to $225 million release Aug 6, 2026 Full-Year 2026 Outlook … Capital expenditures remain in the range of $200 million to $225 million. release Nov 3, 2026 | ||||
| Diluted EPS (company-defined) Fiscal 2026 |
Given $0.93 to $1.01 release Feb 24, 2026
Kept $0.93 to $1.01 release May 5, 2026
Raised $0.95 to $1.01 release Aug 6, 2026
Kept $0.95 to $1.01 release Nov 3, 2026
|
– | No standard number | |
The company's wordsFull-Year 2026 Outlook … Adjusted EPS in the range of $0.93 to $1.01 release Feb 24, 2026 The 2026 outlook below, first provided on February 24, 2026, remains unchanged: … Adjusted EPS in the range of $0.93 to $1.01 release May 5, 2026 Today, Sotera Health is raising its 2026 outlook: … Adjusted EPS improved to a range of $0.95 to $1.01 release Aug 6, 2026 Full-Year 2026 Outlook … Adjusted EPS range remains in the range of $0.95 to $1.01. release Nov 3, 2026 | ||||
| Revenue Fiscal 2026 |
Given $1.23B to $1.25B release Feb 24, 2026
Kept $1.23B to $1.25B release May 5, 2026
Raised $1.24B to $1.25B release Aug 6, 2026
Lowered $1.23B to $1.25B release Nov 3, 2026
|
– | Not reported yet | |
The company's wordsFull-Year 2026 Outlook … Net revenues in the range of $1.233 billion to $1.251 billion, representing constant currency growth of 5.0% to 6.5% and an estimated 100bps foreign currency benefit release Feb 24, 2026 The 2026 outlook below, first provided on February 24, 2026, remains unchanged: … Net revenues in the range of $1.233 billion to $1.251 billion, representing constant currency growth of 5.0% to 6.5% and an estimated 100bps foreign currency benefit release May 5, 2026 Today, Sotera Health is raising its 2026 outlook: … Net revenues range raised to $1.236 billion to $1.254 billion, representing constant currency growth of 5.25% to 6.75% and an estimated 100 basis points of foreign currency benefit release Aug 6, 2026 Full-Year 2026 Outlook … Net revenues in the range of $1.233 billion to $1.250 billion, representing constant currency growth of 5.25% to 6.75%. release Nov 3, 2026 | ||||
| Capital expenditures Fiscal 2025 (ended Dec 31, 2025) |
Given $190.00M to $210.00M release Feb 27, 2025
Lowered $170.00M to $180.00M release Aug 8, 2025
Lowered $125.00M to $135.00M release Nov 4, 2025
|
$138.02M 10-K filed 2026-02-24 |
Above the range | |
The company's wordsToday, Sotera Health is providing its full-year 2025 outlook: … Capital expenditures in the range of $190 million to $210 million, release Feb 27, 2025 Sotera Health is providing an update to its full-year 2025 outlook: … Capital expenditures are now expected to be in the range of $170 million to $180 million, from previous outlook of $190 million to $210 million. release Aug 8, 2025 Today, Sotera Health is updating its 2025 outlook: … Capital expenditures in the range of $125 million to $135 million, from a previous outlook of $170 million to $180 million. release Nov 4, 2025 | ||||
| Diluted EPS (company-defined) Fiscal 2025 (ended Dec 31, 2025) |
Given $0.70 to $0.76 release Feb 27, 2025
Raised $0.75 to $0.82 release Aug 8, 2025
Raised $0.81 to $0.86 release Nov 4, 2025
|
– | No standard number | |
The company's wordsToday, Sotera Health is providing its full-year 2025 outlook: … Adjusted EPS in the range of $0.70 to $0.76, release Feb 27, 2025 Sotera Health is providing an update to its full-year 2025 outlook: … Adjusted EPS range raised to $0.75 - $0.82 from $0.70 - $0.76, release Aug 8, 2025 Today, Sotera Health is updating its 2025 outlook: … Adjusted EPS range raised to $0.81 to $0.86, from a previous outlook of $0.75 to $0.82, release Nov 4, 2025 | ||||
| Capital expenditures Fiscal 2024 (ended Dec 31, 2024) |
Given $205.00M to $225.00M release Feb 27, 2024
Lowered $175.00M to $185.00M release Nov 5, 2024
|
$179.07M 10-K filed 2025-02-27 |
Within the range | |
The company's wordsToday, Sotera Health is providing its full-year 2024 outlook: … Capital expenditures in the range of $205 million to $225 million release Feb 27, 2024 The following range in the 2024 outlook is being updated: … Capital expenditures are now expected to be in the range of $175 million to $185 million, from previous guidance of $205 million to $225 million release Nov 5, 2024 | ||||
| Diluted EPS (company-defined) Fiscal 2024 (ended Dec 31, 2024) |
Given $0.67 to $0.75 release Feb 27, 2024
Kept $0.67 to $0.75 release Nov 5, 2024
|
– | No standard number | |
The company's wordsToday, Sotera Health is providing its full-year 2024 outlook: … Adjusted EPS in the range of $0.67 to $0.75, release Feb 27, 2024 Today, Sotera Health is reaffirming the following 2024 outlook ranges previously provided: … Adjusted EPS in the range of $0.67 to $0.75, release Nov 5, 2024 | ||||
Targets are read from the sentences of the EX-99 exhibits of 8-K item 2.02 filings (15 releases since 2024-01-09), without AI; in outlook tables only the first column is read. The result compares the reported number with the last range given before the period was reported. Results come from SEC's XBRL company facts, as first reported. A company's target can use its own definition (META's capital expenditures include finance lease payments, for example), so read the quote.
Sources
The outlook sentences of each earnings release (8-K item 2.02, exhibit 99), read without AI; results from SEC's XBRL company facts, as first reported.
Also
Earnings releases: each release in full.
Work with it
Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/SHC/export.csv") into a cell.